Harnessing CRISPR/Cas9 to overcome targeted therapy resistance in non?small cell lung cancer: Advances and challenges (Review). Du J, Gong X, Huang R, Zheng B, et al. Oncol Rep 2025;54:111.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Du J, Gong X, Huang R, Zheng B, et al. Harnessing CRISPR/Cas9 to overcome targeted therapy resistance in non?small cell lung cancer: Advances and challenges (Review). Oncol Rep 2025;54:111.
PMID: 40641119